(Q36130584)

12 August 2017

1 reference

title

Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice (English)

1 reference

12 August 2017

1 reference

1 reference

Kristiaan Wouters

1

0 references

Patrick J van Gorp

object named as

Patrick J van Gorp

3

0 references

Ronit Shiri-Sverdlov

object named as

Ronit Shiri-Sverdlov

2

0 references

author name string

Marc van Bilsen

4

1 reference

12 August 2017

Marten H Hofker

5

1 reference

12 August 2017

publication date

1 January 2005

1 reference

Clinical Chemistry and Laboratory Medicine

12 August 2017

published in

1 reference

12 August 2017

volume

43

1 reference

12 August 2017

issue

5

1 reference

12 August 2017

page(s)

470-479

1 reference

Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Genetic modifiers of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Atherosclerosis. the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Familial apolipoprotein E deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Apo E structure determines VLDL clearance and atherosclerosis risk in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Current perspectives on statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Binding of beta-VLDL to heparan sulfate proteoglycans requires lipoprotein lipase, whereas ApoE only modulates binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Rupture of the atherosclerotic plaque: does a good animal model exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Molecular genetics of the LDL receptor gene in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Alterations in human high-density lipoproteins, with or without increased plasma-cholesterol, induced by diets high in cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Peroxisome proliferator-activated receptor alpha,gamma coagonist LY465608 inhibits macrophage activation and atherosclerosis in apolipoprotein E knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.085

Hepatic catabolism of remnant lipoproteins: where the action is.

21 January 2018

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1515/CCLM.2005.085

Variation in susceptibility to atherosclerosis among inbred strains of mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1515/CCLM.2005.085

Polymorphisms at the SRBI locus are associated with lipoprotein levels in subjects with heterozygous familial hypercholesterolemia

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1515/CCLM.2005.085

Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1515/CCLM.2005.085

In silico quantitative trait locus map for atherosclerosis susceptibility in apolipoprotein E-deficient mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1515/CCLM.2005.085

Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1515/CCLM.2005.085

Genetic differences in endothelial cells may determine atherosclerosis susceptibility

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1515/CCLM.2005.085

Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1515/CCLM.2005.085

Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1515/CCLM.2005.085

Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1515/CCLM.2005.085

Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1515/CCLM.2005.085

NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1515/CCLM.2005.085

Identifiers

DOI

10.1515/CCLM.2005.085

1 reference

12 August 2017

1 reference